TY - JOUR
T1 - Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline
AU - Garty, Moshe
AU - Hurwitz, Aryeh
PY - 1980/8
Y1 - 1980/8
N2 - In a randomized crossover study, five normal subjects were given 250‐mg capsules of tetracycline at weekly intervals with cimetidine 300 mg, sodium bicarbonate 2 gm in water, magnesium–aluminium hydroxide gel 30 ml, or water alone. Gastric pH was monitored by radiotelemetry. Antibiotic bioavailability as measured by area under the serum level–time curve, peak serum level, and urinary elimination was not affected by cimetidine or sodium bicarbonate. Magnesium–aluminum hydroxide gel reduced bioavailability by 90%. The data show that gastric pH does not affect absorption of oral tetracycline and that cimetidine can be used in place of antacids to control gastric acid in patients using tetracycline. Clinical Pharmacology and Therapeutics (1980) 28, 203–207; doi:
AB - In a randomized crossover study, five normal subjects were given 250‐mg capsules of tetracycline at weekly intervals with cimetidine 300 mg, sodium bicarbonate 2 gm in water, magnesium–aluminium hydroxide gel 30 ml, or water alone. Gastric pH was monitored by radiotelemetry. Antibiotic bioavailability as measured by area under the serum level–time curve, peak serum level, and urinary elimination was not affected by cimetidine or sodium bicarbonate. Magnesium–aluminum hydroxide gel reduced bioavailability by 90%. The data show that gastric pH does not affect absorption of oral tetracycline and that cimetidine can be used in place of antacids to control gastric acid in patients using tetracycline. Clinical Pharmacology and Therapeutics (1980) 28, 203–207; doi:
UR - http://www.scopus.com/inward/record.url?scp=0018974949&partnerID=8YFLogxK
U2 - 10.1038/clpt.1980.151
DO - 10.1038/clpt.1980.151
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 7398187
AN - SCOPUS:0018974949
VL - 28
SP - 203
EP - 207
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
IS - 2
ER -